1044 NORTH U.S. HIGHWAY ONE, JUPITER, FL
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
Announces Second Quarter 2026 Financial Results
Announces Continued Listing on The Nasdaq Capital Market
2026 Annual Meeting Results; Election of Seth J. Herbst, M.D. as Director
Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
And Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload